Repligen RGEN
NASDAQ RGEN
$181.13 +0.84 (+0.47%)
At close: Aug 21, 2026 · 4:00 PM EDT

Repligen (RGEN) Cash from Investing Activities (2010 - 2026)

Repligen (RGEN) posted quarterly Cash from Investing Activities of -$2.1 million for Q2 2026, up 73.35% year-over-year from -$1.2 million in Q2 2025, and up 47.62% quarter-over-quarter from -$4.0 million in Q1 2026.

Repligen (RGEN) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Repligen (RGEN) has reported Cash from Investing Activities for 17 consecutive years, with -$2.1 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Cash from Investing Activities rose 73.35% year-over-year to -$2.1 million; the TTM figure through Jun 2026 stood at -$222.6 million (down 45.9% YoY), while the FY2025 annual figure was -$298.5 million, down 245.52% from the prior year.
  • Cash from Investing Activities improved to -$2.1 million in Q2 2026 per RGEN's latest filing, from -$4.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $64.8 million in Q2 2023 and bottomed at -$208.7 million in Q4 2025.
  • Historically, Cash from Investing Activities has averaged -$41.5 million across 5 years, with a median of -$9.1 million in 2023.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities surged 347.27% — and 2025, when it sank 786.25%.
  • Repligen's Cash from Investing Activities stood at -$121.3 million in 2022, then slumped by 40.06% to -$169.9 million in 2023, then surged by 61.88% to -$64.8 million in 2024, then sank by 222.32% to -$208.7 million in 2025, then surged by 99.0% to -$2.1 million in 2026.
  • Business Quant data shows RGEN's Cash from Investing Activities at -$2.1 million in Q2 2026, -$4.0 million in Q1 2026, and -$208.7 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -26.60 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -241.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -222.00 Mn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -383.65 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -461.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -43.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -87.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -90.00 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -117.00 Mn
10 Repligen 10.25 Bn 9.24 Bn 110.04 Mn -2.09 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.09 Mn
Jun 30, 2026 -2.09 Mn
Mar 31, 2026 -3.99 Mn
Mar 31, 2026 -3.99 Mn
Dec 31, 2025 -208.74 Mn
Dec 31, 2025 -208.74 Mn
Sep 30, 2025 -7.78 Mn
Sep 30, 2025 -7.78 Mn
Jun 30, 2025 -7.84 Mn
Jun 30, 2025 -7.84 Mn
Mar 31, 2025 -74.11 Mn
Mar 31, 2025 -74.11 Mn
Dec 31, 2024 -64.76 Mn
Dec 31, 2024 -64.76 Mn
Sep 30, 2024 -5.86 Mn
Sep 30, 2024 -5.86 Mn
Jun 30, 2024 -7.40 Mn
Jun 30, 2024 -7.40 Mn
Mar 31, 2024 -8.36 Mn
Mar 31, 2024 -8.36 Mn